Keros Therapeutics, Inc. (KROS)
12.00
+0.31
(+2.65%)
USD |
NASDAQ |
Apr 02, 16:00
12.02
+0.02
(+0.12%)
After-Hours: 20:00
Keros Therapeutics Market Cap : 243.19M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sarepta Therapeutics, Inc. | 2.556B |
| Amicus Therapeutics, Inc. | 4.533B |
| MannKind Corp. | 753.57M |
| PTC Therapeutics, Inc. | 5.530B |
| Insmed, Inc. | 34.50B |
Market Cap Related Metrics
| PE Ratio | 6.772 |
| PS Ratio | 1.888 |
| Price to Book Value | 0.8023 |
| Price to Free Cash Flow | 4.349 |
| Price | 12.00 |
| Earnings Yield | 14.77% |
| Operating PE Ratio | 6.812 |
| Normalized PE Ratio | 6.764 |